2006
DOI: 10.1002/elps.200500951
|View full text |Cite
|
Sign up to set email alerts
|

Electrophoresis of pharmaceutical proteins: Status quo

Abstract: The biotechnology industry has undergone rapid growth in recent years largely due to the development and success of protein-based therapeutics for a wide range of disorders. Similar to traditional pharmaceuticals, characterization of a therapeutic protein for its physicochemical properties, process monitoring and lot release is crucial. Electrophoresis in the slab-gel format has and continues to be a mainstay of the protein laboratory; and more recently, CE has begun to make significant inroads for protein ana… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
14
0

Year Published

2008
2008
2017
2017

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 27 publications
(14 citation statements)
references
References 50 publications
0
14
0
Order By: Relevance
“…Over the last years, mAbs have been introduced for the treatment of several diseases, such as HIV, autoimmune disorders, and cancer (http://www.phrma.org/files/Biotech%202006.pdf, [23]). mAbs are subject to posttranslational modifications that occur during the production of the protein.…”
Section: Monoclonal Igg 1 Antibodymentioning
confidence: 99%
“…Over the last years, mAbs have been introduced for the treatment of several diseases, such as HIV, autoimmune disorders, and cancer (http://www.phrma.org/files/Biotech%202006.pdf, [23]). mAbs are subject to posttranslational modifications that occur during the production of the protein.…”
Section: Monoclonal Igg 1 Antibodymentioning
confidence: 99%
“…For example, in intact-protein glycoprofiling, electrophoretic methods without prior derivatization [e.g., capillary isoelectric focusing (CIEF), capillary-gel electrophoresis (CGE) and capillary-zone electrophoresis (CZE)] have become methods of choice in pharmacopeias and companies in the context of, e.g., product development, lot release and stability analyses [12,13]. Glyco-analysis at the protein level has the great advantage of reducing sample preparation to a minimum, thereby reducing costs and errors.…”
Section: Current Methods In Glycosylation Analysis Of Biopharmaceuticalsmentioning
confidence: 99%
“…8) . CE is an efficient and highly sensitive separation method that is widely used in biochemical and pharmaceutical research (Kostal, Katzenmeyer, & Arriaga, 2008;Little, Paquette, & Roos, 2006;McEvoy, Marsh, Altria, Donegan, & Power, 2008). CE is fast and cost-effective, and allows high sample throughput, easy automation, separation efficiency, precision, and only requires nanoliter volumes of sample (Dolnik, 2006(Dolnik, , 2008.…”
Section: Limitations Of D2d Sds-page and Advantages Of Cementioning
confidence: 99%